Charlotte Robinson

DocwireNews

Oral alkali therapy can raise serum bicarbonate concentrations and has been associated with slowing chronic kidney disease (CKD) progression. Researchers led by Bhupinder Singh performed a post hoc analysis from the phase 3 VALOR-CKD trial to study the relationship between serum bicarbonate concentrations and CKD progression. They reported results at the National Kidney Foundation Spring Clinical Meetings.VALOR-CKD was conducted to assess the safety and efficacy of veverimer, a nonabsorbed polymer that removes hydrochloric acid from the gastrointestinal tract. The randomized, double-blind, placebo-controlled trial included 1480 patients who had CKD (estimated glomerular filtration rate [eGFR], 20-40 mL/min/1.73 m2) and metabolic acidosis (serum bicarbonate, 12-20 mEq/L). Following single-blind active treatment for up to 8.0 weeks, randomized patient groups received either veverimer or placebo and were followed for a median of 24.5 months.VALOR-CKD did not find a slowdown of CKD progression (defined as time to first kidney composite end point [KCE] of a confirmed reduction in eGFR &ge;40%, end-stage kidney disease requiring dialysis or transplantation, or death due to kidney disease).In their post hoc analysis, Singh&rsquo;s team used a Cox proportional hazards model to assess the relationships among three levels of average serum bicarbonate concentrations reached throughout the randomized treatment period (&lt;20, 20 to &lt;22, and &ge;22 mEq/L) and the KCE. They found that patients with average serum bicarbonate concentrations 20 to &lt;22 and &ge;22 mEq/L had a reduced risk of KCE&mdash;hazard ratio (HR), 0.67 (95% CI, 0.49-0.90); P&lt;.0078 and HR, 0.50 (95% CI, 0.37-0.67); P&lt;.0001, respectively&mdash;versus those with concentrations &lt;20 mEq/L. This was true regardless of whether patients were receiving veverimer or placebo.The researchers asserted that their results support that higher serum bicarbonate concentrations in patients with CKD and metabolic acidosis are associated with slower CKD progression.Source: Singh B, Tangri N, Bushinsky D, et al. <a href="https://doi.org/10.1053/j.ajkd.2024.01.351" target="_blank" rel="noopener">Serum bicarbonate concentrations and CKD progression in patients with metabolic acidosis: evidence from VALOR-CKD.</a> Presented at the National Kidney Foundation Spring Clinical Meetings 2024; May 14-18, 2024; Long Beach, California.

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Higher Serum Bicarbonate Concentrations, Slower CKD Progression With Metabolic Acidosis

NKF Spring Clinical Meetings 2024

In patients with chronic kidney disease (CKD) and metabolic acidosis, higher serum concentrations were associated with slower CKD progression.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe